Skip to main content
. 2019 Feb 18;30(6):921–926. doi: 10.1093/annonc/mdz055

Figure 1.

Figure 1.

Correlative science results: tumor-infiltrating lymphocytes (TILs), PIK3CA status and PAM50 intrinsic subtype at baseline (all patients). (A) PAM50 intrinsic subtype distribution according to molecular response and pathologic complete response (pCR) rates according to PAM50 and molecular response; (B) distribution of TILs and (C) PIK3CA mutations at baseline in all patients.